Statistical analysis plan for a randomized controlled trial examining pedometer-based walking intervention in patients with heart failure with reduced ejection fraction: the WATCHFUL trial
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu randomizované kontrolované studie, multicentrická studie, časopisecké články
Grantová podpora
NV18-09-00146
Agentura Pro Zdravotnický Výzkum České Republiky
PubMed
37587489
PubMed Central
PMC10433657
DOI
10.1186/s13063-023-07516-5
PII: 10.1186/s13063-023-07516-5
Knihovny.cz E-zdroje
- Klíčová slova
- Functional capacity, Garmin, Intention-to-treat analysis, Phone counseling, Physical activity, Pragmatic trial, Self-monitoring, Six-minute walk test, Tele-rehabilitation, Wearables,
- MeSH
- aktigrafie MeSH
- chůze MeSH
- COVID-19 * MeSH
- lidé MeSH
- pandemie MeSH
- srdeční selhání * diagnóza terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- randomizované kontrolované studie MeSH
BACKGROUND: Physical activity is an effective management strategy for heart failure with reduced ejection fraction, but patients' compliance is challenging. Walking is a suitable form of physical activity due to its convenience and sustainability, and it can potentially improve functional capacity in heart failure patients. OBJECTIVES: The WATCHFUL trial aims to determine whether a pedometer-based walking intervention combined with face-to-face sessions and regular telephone contact improves functional capacity in heart failure patients. METHODS: The WATCHFUL trial is a 6-month multicenter, parallel-group, randomized, controlled, superiority trial with a 6-month follow-up. A total of 202 patients were recruited for the trial. The primary analysis will evaluate the change in distance walked during the 6-min walk test from baseline to 6 months based on the intention-to-treat population; the analysis will be performed using a linear mixed-effect model adjusted for baseline values. Missing data will be imputed using multiple imputations, and the impact of missing data will be assessed using a sensitivity analysis. Adverse events are monitored and recorded throughout the trial period. DISCUSSION: The trial has been designed as a pragmatic trial with a scalable intervention that could be easily translated into routine clinical care. The trial has been affected by the COVID-19 pandemic, which slowed patients' recruitment and impacted their physical activity patterns. CONCLUSIONS: The present publication provides details of the planned statistical analyses for the WATCHFUL trial to reduce the risks of reporting bias and erroneous data-driven results. TRIAL REGISTRATION: ClinicalTrials.gov (identifier: NCT03041610, registered: 3/2/2017).
Department of Cardiology Tomas Bata Regional Hospital Zlin Czech Republic
Department of Internal Medicine 1 Cardiology University Hospital Olomouc Olomouc Czech Republic
Edumed S R O Broumov Czech Republic
Faculty of Medicine in Hradec Kralove Charles University Prague Czech Republic
Faculty of Physical Education and Sport Charles University Prague Czech Republic
Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic
University Hospital Hradec Kralove Hradec Králové Czech Republic
Zobrazit více v PubMed
Becher PM, Lund LH, Coats AJS, Savarese G. An update on global epidemiology in heart failure. Eur Heart J. 2022;43:3005–3007. doi: 10.1093/eurheartj/ehac248. PubMed DOI
Toth PP, Gauthier D. Heart failure with preserved ejection fraction: disease burden for patients, caregivers, and the health-care system. Postgrad Med. 2021;133:140–145. doi: 10.1080/00325481.2020.1842621. PubMed DOI
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79:e263–421. doi: 10.1016/j.jacc.2021.12.012. PubMed DOI
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42:ehab368. PubMed
Seid MA, Abdela OA, Zeleke EG. Adherence to self-care recommendations and associated factors among adult heart failure patients. PLoS ONE. 2019;14:e0211768. doi: 10.1371/journal.pone.0211768. PubMed DOI PMC
Piepoli MF, Binno S, Corrà U, Seferovic P, Conraads V, Jaarsma T, et al. ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients. Eur J Heart Fail. 2015;17:631–638. doi: 10.1002/ejhf.271. PubMed DOI
Bullard T, Ji M, An R, Trinh L, Mackenzie M, Mullen SP. A systematic review and meta-analysis of adherence to physical activity interventions among three chronic conditions: cancer, cardiovascular disease, and diabetes. BMC Public Health. 2019;19:636. doi: 10.1186/s12889-019-6877-z. PubMed DOI PMC
Bozkurt B, Fonarow GC, Goldberg LR, Guglin M, Josephson RA, Forman DE, et al. Cardiac rehabilitation for patients with heart failure: JACC expert panel. J Am Coll Cardiol. 2021;77:1454–1469. doi: 10.1016/j.jacc.2021.01.030. PubMed DOI
Larsen RT, Wagner V, Korfitsen CB, Keller C, Juhl CB, Langberg H, et al. Effectiveness of physical activity monitors in adults: systematic review and meta-analysis. BMJ. 2022;376:e068047. doi: 10.1136/bmj-2021-068047. PubMed DOI PMC
Vetrovsky T, Borowiec A, Juřík R, Wahlich C, Śmigielski W, Steffl M, et al. Do physical activity interventions combining self-monitoring with other components provide an additional benefit compared with self-monitoring alone? A systematic review and meta-analysis. Brit J Sport Med. 2022;56:1366–1374. doi: 10.1136/bjsports-2021-105198. PubMed DOI PMC
Chaudhry UAR, Wahlich C, Fortescue R, Cook DG, Knightly R, Harris T. The effects of step-count monitoring interventions on physical activity: systematic review and meta-analysis of community-based randomised controlled trials in adults. Int J Behav Nutr Phy. 2020;17:129. doi: 10.1186/s12966-020-01020-8. PubMed DOI PMC
O’Connor EA, Evans CV, Rushkin MC, Redmond N, Lin JS. Behavioral counseling to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors. JAMA. 2020;324:2076–2094. doi: 10.1001/jama.2020.17108. PubMed DOI
Snoek JA, Prescott EI, van der Velde AE, Eijsvogels TMH, Mikkelsen N, Prins LF, et al. Effectiveness of home-based mobile guided cardiac rehabilitation as alternative strategy for nonparticipation in clinic-based cardiac rehabilitation among elderly patients in Europe. Jama Cardiol. 2021;6:463–468. doi: 10.1001/jamacardio.2020.5218. PubMed DOI PMC
Hardeman W, Mitchell J, Pears S, Emmenis MV, Theil F, Gc VS, et al. Evaluation of a very brief pedometer-based physical activity intervention delivered in NHS Health Checks in England: the VBI randomised controlled trial. Plos Med. 2020;17:e1003046. doi: 10.1371/journal.pmed.1003046. PubMed DOI PMC
Vetrovsky T, Siranec M, Parenica J, Griva M, Stastny J, Precek J, et al. Effect of a 6-month pedometer-based walking intervention on functional capacity in patients with chronic heart failure with reduced (HFrEF) and with preserved (HFpEF) ejection fraction: study protocol for two multicenter randomized controlled trials. J Transl Med. 2017;15:153. doi: 10.1186/s12967-017-1257-x. PubMed DOI PMC
Lewis JA. Statistical principles for clinical trials (ICH E9): an introductory note on an international guideline. Statist Med. 1999;18:1903–1942. doi: 10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.0.CO;2-F. PubMed DOI
Hemming K, Kearney A, Gamble C, Li T, Jüni P, Chan A-W, et al. Prospective reporting of statistical analysis plans for randomised controlled trials. Trials. 2020;21:898. doi: 10.1186/s13063-020-04828-8. PubMed DOI PMC
Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Doré C, et al. Guidelines for the content of statistical analysis plans in clinical trials. JAMA. 2017;318:2337–2343. doi: 10.1001/jama.2017.18556. PubMed DOI
Shoemaker MJ, Curtis AB, Vangsnes E, Dickinson MG. Triangulating clinically meaningful change in the six-minute walk test in individuals with chronic heart failure: a systematic review. Cardiopulm Phys Ther J. 2012;23:5–15. doi: 10.1097/01823246-201223030-00002. PubMed DOI PMC
Vetrovsky T, Siranec M, Marencakova J, Tufano JJ, Capek V, Bunc V, et al. Validity of six consumer-level activity monitors for measuring steps in patients with chronic heart failure. PLoS ONE. 2019;14:e0222569. doi: 10.1371/journal.pone.0222569. PubMed DOI PMC
Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726. doi: 10.7326/0003-4819-152-11-201006010-00232. PubMed DOI
Pocock SJ, Ariti CA, McMurray JJV, Maggioni A, Køber L, Squire IB, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2012;34:ehs337–1413. PubMed
Vetrovsky T, Clark CCT, Bisi MC, Siranec M, Linhart A, Tufano JJ, et al. Advances in accelerometry for cardiovascular patients: a systematic review with practical recommendations. Esc Heart Fail. 2020;7:2021–2031. doi: 10.1002/ehf2.12781. PubMed DOI PMC
Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8:3–15. doi: 10.1177/096228029900800102. PubMed DOI
Vetrovsky T, Frybova T, Gant I, Semerad M, Cimler R, Bunc V, et al. The detrimental effect of COVID-19 nationwide quarantine on accelerometer-assessed physical activity of heart failure patients. Esc Heart Fail. 2020;7:2093–2097. doi: 10.1002/ehf2.12916. PubMed DOI PMC
ClinicalTrials.gov
NCT03041610